20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is ATORVASTATIN CALCIUM (BUTYLATED HYDROXY ANISOLE PREMIX), with a corresponding US DMF Number 25902.
Remarkably, this DMF maintains an Active status since its submission on March 23, 2012, highlighting commitment to regulatory compliance.